A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Commentary: Pill to terminate early pregnancies unlikely to become available without a prescription for years, if ever, experts say; the pill, mifepristone, combined with second drug misoprostol, is only available through a certified doctor's prescription
Published: June 24, 2022 by Reuters
Analysts on Enanta suing Pfizer over Covid pill Paxlovid: SVB Securities says it's unclear whether Enanta is in the right, noting patent dates might not prove who 'invented' technology first; RBC says it could take years for lawsuit to reach conclusion
Published: June 22, 2022 by Investor's Business Daily
Enanta files suit in US District Court against Pfizer seeking damages for copyright infringement related to Paxlovid nirmatrelvir, ritonavir tablets; Enanta applied for a patent for a coronavirus protease inhibitor in 2020 and received patent this month
Published: June 22, 2022 by Business Wire
AbbVie submits supplemental new drug application to FDA for Atogepant Qulipt, a preventive treatment for chronic migraines in adults; migraines affect 39 million people in US, are highest cause of disability for those under 50 years of age
Published: June 22, 2022 by PR Newswire
Launch prices for new drugs increased 20% per year from 2008 to 2021, growing from median price of US$2,115 per year in 2008 to US$180,007 per year in 2021; drug launch prices outpacing prices for other healthcare services: study
Published: June 21, 2022 by The Breeze (James Madison University)

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count